AdvaMedDx Statement on Proposed Medicare Clinical Laboratory Fee Schedule Cuts

You are here

AdvaMedDx Statement on Proposed Medicare Clinical Laboratory Fee Schedule Cuts

February 15, 2012

WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, released the following statement regarding proposed cuts in the Medicare Clinical Laboratory Fee Schedule:

“AdvaMedDx is strongly opposed to further cuts in the Medicare Clinical Laboratory Fee Schedule as has been put forward in the proposed ‘Doc Fix’ deal. The proposed cuts run counter to developing the next generation of lab tests that will allow treatments to be tailored to meet the needs of specific individuals, improving care and reducing costs.

“The laboratory fee schedule is already facing five years of successive cuts under the Affordable Care Act continuing until 2015 resulting in a 9 percent cut, the largest cut among all Part B providers.  We are gravely concerned that these additional cuts – estimated to provide savings of nearly $3 billion – will delay or deny patient access to life-saving and life-enhancing innovative diagnostic tests. 

“While less than 2 percent of all Medicare spending, clinical laboratory testing has been subject to freezes in payments and significant cuts over the last two decades. Medicare payment amounts for clinical laboratory services have been reduced by about 40 percent in real (inflation-adjusted) terms over the past 20 years.  We urge Congress to reconsider and reject these proposed cuts.”

For more information, please contact: Wanda Moebius @ (202) 434-7240


AdvaMedDx member companies produce advanced, in vitro diagnostic tests that facilitate evidence-based medicine, improve quality of patient care, enable early detection of disease and reduce overall health care costs. Functioning as an association within AdvaMed, AdvaMedDx is the only multi-faceted, policy organization that deals exclusively with issues facing in vitro diagnostic companies both domestically in the United States and abroad. For more information, visit